top of page

Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 4-6 October 2016

The Committee adopted by consensus positive opinions for initial marketing authorisationapplications for:

HALAGON (halofuginone), from Emdoka BVBA, a generic antiparasitic product for the reduction and prevention of diarrhoea due to infection with Cryptosporidiium parvum in newborn calves; and

Cepedex (dexmedetomidine), from CP-Pharma Handelsgesellschaft mbH, a generic psycholeptic product for sedation and analgesia in dogs and cats.

Click on this link for more information.


Today's News
Follow us
  • LinkedIn Social Icon
  • Vimeo Social Icon
Newsletter on Pharma Legislation
the newsletter of
bottom of page